Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)
María Isabel Benítez‐Carabante, David Bueno, Laura Alonso García, Ivan Lopez, Júlia Marsal, José María Fernandez Navarro, María Luz Uria Oficialdegui, Melissa Panesso, Blanca Molina, Cristina Beléndez, Pilar Palomo, Antonio Pérez‐Martínez, Cristina Díaz de Heredia
Topics & Concepts
Thrombotic microangiopathyMedicineEculizumabInterquartile rangeInternal medicineRetrospective cohort studyTransplantationHematopoietic stem cell transplantationGastroenterologyCohortSurgeryDiseaseImmunologyComplement systemAntibodyComplement system in diseasesRenal Transplantation Outcomes and TreatmentsTransplantation: Methods and Outcomes